Showing results (151-160 of 300) with videos related to

Sort By:
Pageof 30
Blood|November 9, 2000
Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasiaR A Mesa, C A Hanson, S V Rajkumar, et al.
Blood Reviews|June 26, 2016
The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advancesT Barbui, J Thiele, H Gisslinger, et al.
Leukemia|November 17, 2010
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitationsA Pardanani, A M Vannucchi, F Passamonti, et al.
Leukemia|March 20, 2009
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patientsA Pardanani, T Lasho, G Smith, et al.
Leukemia|August 21, 2010
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutationsA Pardanani, T Lasho, C Finke, et al.
European Journal of Haematology|February 13, 2001
Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasiaA Tefferi, T Jiménez, L A Gray, et al.
Blood|March 25, 2000
Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patientsA Tefferi, R A Mesa, D M Nagorney, et al.
Chest|September 14, 2001
Unexplained pulmonary hypertension in chronic myeloproliferative disordersD Dingli, J P Utz, M J Krowka, et al.
Cancer|February 1, 1994
Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Resolution with tumor debulkingD J Tiede, A Tefferi, R Kochhar, et al.
Blood Reviews|March 1, 1993
Karyotypic analysis in primary myelodysplastic syndromesP Noël, A Tefferi, R V Pierre, et al.
Pageof 30